- Report of Foreign Issuer (6-K)
October 10 2008 - 1:33PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
9 October 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
Protherics PLC
6 monthly Block Listing Return
Approved Share Option Scheme
London, UK; Brentwood, TN; 9 October 2008 -
Protherics PLC ("Protherics" or the "Company"), the international
biopharmaceutical company focused on critical care and cancer, in accordance with
Listing Rule 3.5.6, notifies the following details in respect of
the block listing for its Approved Share Option Scheme:
|
Name of
applicant
:
|
Protherics PLC
|
|
Name of scheme:
|
Protherics PLC Approved Executive Share Option Scheme
|
|
Period of return:
|
From:
|
9 April 2008
|
To:
|
8 October 2008
|
|
Balance of
unallotted
securities
under scheme at beginning of
period:
|
294,838
|
|
The amount by which the block scheme has been
increased during the period:
|
Nil
|
|
Number of
securities
issued/allotted under
scheme during period:
|
19,070
|
|
Balance under scheme not yet issued/allotted at end of
period
|
275,768
|
| Ends |
For further information please contact:
|
Protherics
|
|
|
Nick Staples, Director of Corporate Affairs
|
+44
(0) 7919 480510
|
|
Julie Vickers, Company
Secretary
|
+44
(0)1928 518010
|
|
|
|
|
Financial Dynamics
- press
enquiries
|
|
|
London: Ben Atwell, Lara Mott
|
+44
(0) 20 7831 3113
|
|
New York: John Capodanno
|
+1
212 850 5600
|
Or visit
www.protherics.com
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
|
|
Date: 9 October 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
|
Finance Director
|
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
